Evidence map›Paper›PMID 29672980›Full record

ArticleProtein science : a publication of the Protein Society2018

Using disruptive insertional mutagenesis to identify the in situ structure-function landscape of the Shigella translocator protein IpaB.

Michael L Barta, Shoichi Tachiyama, Meenakumari Muthuramalingam, Olivia Arizmendi, Cecilia E Villanueva, Kasra X Ramyar, Brian V Geisbrecht, Scott Lovell, Kevin P Battaile, Wendy L Picking and 1 more

Abstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. TheMicroorganisms · 2021
    Review
  9. Structural Insights ofFrontiers in cellular and infection microbiology · 2021
    Article
  10. Article
  11. The T3SS ofMicroorganisms · 2020
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Michael L BartaHiguchi Biosciences Center, University of Kansas, Lawrence, Kansas, 66047.
Shoichi TachiyamaDepartment of Molecular Biosciences, University of Kansas, Lawrence, Kansas, 66045.
Meenakumari MuthuramalingamHiguchi Biosciences Center, University of Kansas, Lawrence, Kansas, 66047.ORCID 0000-0001-5635-325X
Olivia ArizmendiHiguchi Biosciences Center, University of Kansas, Lawrence, Kansas, 66047.
Cecilia E VillanuevaDepartment of Molecular Biosciences, University of Kansas, Lawrence, Kansas, 66045.
Kasra X RamyarDepartment of Biochemistry and Molecular Biophysics, Kansas State University, Manhattan, Kansas, 66506.
Brian V GeisbrechtDepartment of Biochemistry and Molecular Biophysics, Kansas State University, Manhattan, Kansas, 66506.
Scott LovellProtein Structure Laboratory, Del Shankel Structural Biology Center, University of Kansas, Lawrence, KS, 66045.
Kevin P BattaileIMCA-CAT, Hauptman-Woodward Medical Research Institute, Argonne, Illinois, 60439.
Wendy L PickingDepartment of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas, 66047.
William D PickingHiguchi Biosciences Center, University of Kansas, Lawrence, Kansas, 66047.

Funding

Protein Structure Laboratory P30GM110761 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI HANZLIK, ROBERT P · 2014 to 2018
$5.6M
Assembly/function of the sorting platform of the Shigella type III secretion apparatusR01AI123351 · NIAID · UNIVERSITY OF KANSAS LAWRENCE · PI PICKING, WILLIAM D. · 2016 to 2020
$2.2M
The multiple states of IpaB Shigella type III secretionR01AI099489 · NIAID · UNIVERSITY OF KANSAS LAWRENCE · PI PICKING, WILLIAM D. · 2013 to 2017
$2.2M
NIAID NIH HHS R01 AI099489NIAID NIH HHS R01 AI123351NIGMS NIH HHS P30 GM110761
6 · The paper itself

Abstract

Bacterial type III secretion systems (T3SS) are used to inject proteins into mammalian cells to subvert cellular functions. The Shigella T3SS apparatus (T3SA) is comprised of a basal body, cytoplasmic sorting platform and exposed needle with needle "tip complex" (TC). TC maturation occurs when the translocator protein IpaB is recruited to the needle tip where both IpaD and IpaB control secretion induction. IpaB insertion into the host membrane is the first step of translocon pore formation and secretion induction. We employed disruptive insertional mutagenesis, using bacteriophage T4 lysozyme (T4L), within predicted IpaB loops to show how topological features affect TC functions (secretion control, translocon formation and effector secretion). Insertions within the N-terminal half of IpaB were most likely to result in a loss of steady-state secretion control, however, all but the two that were not recognized by the T3SA retained nearly wild-type hemolysis (translocon formation) and invasiveness levels (effector secretion). In contrast, all but one insertion in the C-terminal half of IpaB maintained secretion control but were impaired for hemolysis and invasion. These nature of the data suggest the latter mutants are defective in a post-secretion event, most likely due to impaired interactions with the second translocator protein IpaC. Intriguingly, only two insertion mutants displayed readily detectable T4L on the bacterial surface. The data create a picture in which the makeup and structure of a functional T3SA TC is highly amenable to physical perturbation, indicating that the tertiary structure of IpaB within the TC is more plastic than previously realized.

Indexed as

Bacterial ProteinsAnimalsAntigens, BacterialCells, CulturedErythrocytesHemolysisMutagenesis, InsertionalSheepType III Secretion SystemsX-Ray DiffractionAntigens, BacterialBacterial ProteinsipaB protein, ShigellaType III Secretion SystemsIpaBShigellatranslocontype III secretion

Identifiers

PMID29672980
PMCPMC6153406

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.